当前位置: 首页 > 期刊 > 《中华现代临床医学杂志》 > 2006年第5期
编号:10965899
肺癌晚期伴其他部位转移时的诊治体会
http://www.100md.com 《中华现代临床医学杂志》 2006年第5期
肺肿瘤,,肺肿瘤;肿瘤转移;诊断;治疗,1临床资料,2结果,3讨论,【参考文献】
     【摘要】 目的 探索对肺癌晚期伴有转移时的可行治疗方法。方法 将2000年1月~2005年4月38例肺癌伴胸膜、胸壁、另叶肺、骨、肝、颅内转移的病人分成综合治疗、单纯手术、单纯化疗、单纯支持治疗四组进行治疗。结果 综合治疗组、单纯手术组、单纯化疗组、单纯支持治疗组中位生存期分别为15、10、11、6个月。1年生存率分别为7/9(77.8%)、4/8(50.0%)、5/10(50.0%)、0/11(0)。2年生存率分别为4/9(44.4%)、0/8(0)、0/10(0)、0/11(0)。结论 重视肺癌晚期患者自述固定疼痛部位的追踪检查,提高接诊时恰当推荐治疗方案的能力,把握对病人的依从性方面的处理技巧,改变原有的观念,对晚期肺癌PS 2级以上的病人在经济能支持、观念能接受时,采用多种治疗手段组合的综合治疗,对肺癌晚期伴有转移的病人延长生存期和提高生活质量是有益的。但何为最佳治疗组合顺序仍是一个值得探讨的问题。

    【关键词】 肺肿瘤;肿瘤转移;诊断;治疗

    Experience of the treatment to advanced lung cancer with metastasis in other position

    LUO Nan,LI Qiong,ZHAO Xia,et al.Department of Cardiothoracic Surgery,The Fourth Peoples Hospital of Zigong,The Affiliated Zigong Hospital of Luzhou Medical College,Zigong 643000,China

    【Abstract】 Objective To explore therapieutic approaches to advanced lung cancer with metastasis in other position.Methods From January 2000 to April 2005,38 cases of lung cancer with metastasis in pleura,thorax,other lobe of the lung,bone,liver and brain were allocated to 4 groups theated with 4 methods that integrated treatment,only operation,only chemotherapy and support treatment.Results The median survival time were 15,10,11,6 months and one-year survival rate was 7/9(77.8%),4/8(50.0%),5/10(50.0%),0/11(0);2year survival rate was 4/9(44.4%),0/8(0),0/10(0),0/11(0) respectively.Conclusion It is benefit to prolong survival time and raise life quality if careful following-up is performed.It includes tracking fixed pain position of patients enhancing ability of persuasion and control patients that were treated,and selecting and using integrated treatment to patients with PS 2 over.But it is still worthy advanced lung cancer beyond to explore an optimum order in integrated treatment. ......

您现在查看是摘要页,全文长 9664 字符